<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref8">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barr</surname>
    <given-names>I. G.</given-names>
   </name>
   <name>
    <surname>Donis</surname>
    <given-names>R. O.</given-names>
   </name>
   <name>
    <surname>Katz</surname>
    <given-names>J. M.</given-names>
   </name>
   <name>
    <surname>McCauley</surname>
    <given-names>J. W.</given-names>
   </name>
   <name>
    <surname>Odagiri</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Trusheim</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2018</year>). 
  <article-title>Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness</article-title>. 
  <source>NPJ Vaccines</source>
  <volume>3</volume>, 
  <fpage>1</fpage>–
  <lpage>5</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41541-018-0079-z</pub-id>, PMID: 
  <?supplied-pmid 30323955?>
  <pub-id pub-id-type="pmid">29354293</pub-id>
 </mixed-citation>
</ref>
